Table 1.
Patient characteristics (all inclusions).
| Total Cohort (n = 26) | |
|---|---|
| Age, median (IQR) | 71 (12) |
| Sex, n women (%) | 7 (27) |
| BMI ¶, median in kg/m2 (IQR) | 23 (4) |
| Smoking, n (%) | |
| No | 6 (23) |
| Currently | 7 (31) |
| Former (>2 years ago) | 11 (42) |
| Unknown | 1 (4) |
| Diabetes mellitus, n present (%) | 10 (39) |
| Any symptom, n (%) | 21 (81) |
| Jaundice | 8 (31) |
| Epigastric pain | 13 (50) |
| Weight loss | 10 (39) |
| CA19.9 > 37 kU/L, n (%) | 20 (77) |
| Treatment naive, n (%) | 21 (81) |
| Resectability of PC, n (%) | |
| Resectable | 8 (31) |
| Borderline resectable | 2 (8) |
| Locally advanced PC | 16 (62) |
| Location mass, n (%) | |
| Uncinate/head | 16 (62) |
| Neck/corpus | 7 (27) |
| Tail | 3 (12) |
| CBD stent in situ, n (%) | 8 (31) |
¶ BMI is missing for 5 patients. IQR = interquartile range, PC = pancreatic cancer, CBD = common bile duct.